Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 239 of 1,261
  1. US 11446397

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  2. US 11446365

    Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  3. US 11447541

    Anti-coronavirus antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  4. US 11446310

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  5. US 11446331

    Wound healing and tissue engineering

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  6. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  7. US 11446332

    Combinatorial cancer immunotherapy

    Senti Biosciences, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  8. US 11446271

    Methods and compositions for increasing the potency of antifungal agents

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  9. US 11446253

    Ionic liquids for internal delivery

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  10. US 11446279

    Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  11. US 11446342

    Composite probiotics and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  12. US 11450420

    Secure smart dosing system with automated delivery, measurement, and management for pills

    Vivera Pharmaceuticals Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  13. US 11447453

    Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  14. US 11440943

    Therapeutic interferon alpha 1 proteins

    Orionis Biosciences, Inc · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  15. US 11440939

    Anticancer peptides

    IDP DISCOVERY PHARMA, S.L. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  16. US 11441184

    Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  17. US 11440885

    Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  18. US 11440963

    Combination PDL1 and TGF-beta blockade in patients with HPV+ malignancies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  19. US 11440883

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  20. US 11440951

    Therapeutic antibodies to Marburg virus

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  21. US 11440907

    Antiproliferation compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  22. US 11439669

    C. novyi for the treatment of solid tumors in humans

    Biomed Valley Discoveries, Inc. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  23. US 11440950

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  24. US 11439666

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Sangamo Therapeutics, Inc. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.